Cargando…
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer tha...
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402077/ https://www.ncbi.nlm.nih.gov/pubmed/32749634 http://dx.doi.org/10.1007/s40487-020-00124-2 |
| _version_ | 1783566683295711232 |
|---|---|
| author | de las Heras, Begoña Saini, Kamal S. Boyle, Frances Ades, Felipe de Azambuja, Evandro Bozovic-Spasojevic, Ivana Romano, Marco Capelan, Marta Prasad, Rajeev Pattu, Pugazhenthi Massard, Christophe Portera, Chia Saini, Monika Lamba Singh, Brajendra Prasad Venkitaraman, Ramachandran McNally, Richard Leone, Manuela Grande, Enrique Gupta, Sudeep |
| author_facet | de las Heras, Begoña Saini, Kamal S. Boyle, Frances Ades, Felipe de Azambuja, Evandro Bozovic-Spasojevic, Ivana Romano, Marco Capelan, Marta Prasad, Rajeev Pattu, Pugazhenthi Massard, Christophe Portera, Chia Saini, Monika Lamba Singh, Brajendra Prasad Venkitaraman, Ramachandran McNally, Richard Leone, Manuela Grande, Enrique Gupta, Sudeep |
| author_sort | de las Heras, Begoña |
| collection | PubMed |
| description | The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future. |
| format | Online Article Text |
| id | pubmed-7402077 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74020772020-08-05 Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months de las Heras, Begoña Saini, Kamal S. Boyle, Frances Ades, Felipe de Azambuja, Evandro Bozovic-Spasojevic, Ivana Romano, Marco Capelan, Marta Prasad, Rajeev Pattu, Pugazhenthi Massard, Christophe Portera, Chia Saini, Monika Lamba Singh, Brajendra Prasad Venkitaraman, Ramachandran McNally, Richard Leone, Manuela Grande, Enrique Gupta, Sudeep Oncol Ther Commentary The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future. Springer Healthcare 2020-08-04 /pmc/articles/PMC7402077/ /pubmed/32749634 http://dx.doi.org/10.1007/s40487-020-00124-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Commentary de las Heras, Begoña Saini, Kamal S. Boyle, Frances Ades, Felipe de Azambuja, Evandro Bozovic-Spasojevic, Ivana Romano, Marco Capelan, Marta Prasad, Rajeev Pattu, Pugazhenthi Massard, Christophe Portera, Chia Saini, Monika Lamba Singh, Brajendra Prasad Venkitaraman, Ramachandran McNally, Richard Leone, Manuela Grande, Enrique Gupta, Sudeep Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title | Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title_full | Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title_fullStr | Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title_full_unstemmed | Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title_short | Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months |
| title_sort | cancer treatment and research during the covid-19 pandemic: experience of the first 6 months |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402077/ https://www.ncbi.nlm.nih.gov/pubmed/32749634 http://dx.doi.org/10.1007/s40487-020-00124-2 |
| work_keys_str_mv | AT delasherasbegona cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT sainikamals cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT boylefrances cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT adesfelipe cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT deazambujaevandro cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT bozovicspasojevicivana cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT romanomarco cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT capelanmarta cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT prasadrajeev cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT pattupugazhenthi cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT massardchristophe cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT porterachia cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT sainimonikalamba cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT singhbrajendraprasad cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT venkitaramanramachandran cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT mcnallyrichard cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT leonemanuela cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT grandeenrique cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months AT guptasudeep cancertreatmentandresearchduringthecovid19pandemicexperienceofthefirst6months |